ZBTB6 is a zinc finger and BTB domain-containing transcription repressor that plays a regulatory role in multiple biological processes. The protein contains five Krüppel-type zinc finger motifs and an N-terminal BTB/POZ domain 1, which facilitates protein-protein interactions and chr9 remodeling activities 2. In breast cancer, ZBTB6 is highly expressed and promotes tumor progression by binding to the ARHGAP6 promoter to repress its transcription, thereby activating the STAT3 signaling pathway 3. ZBTB6 knockdown inhibits cancer cell viability and cycle progression while promoting apoptosis, and suppresses tumor growth in vivo 3. The gene has been identified as a master transcriptional regulator in multiple disease contexts: it regulates genes involved in secondary hyperparathyroidism proliferation 4 and is part of an energy metabolism-based prognostic signature for esophageal carcinoma 5. Additionally, ZBTB6 functions as a positive regulator in nasopharyngeal carcinoma, controlling T cell receptor signaling pathway genes 6. These findings suggest ZBTB6 serves as a potential prognostic biomarker and therapeutic target across multiple cancer types.